CLOUGH CAPITAL PARTNERS L P – Apellis Pharmaceuticals, Inc. Transaction History
CLOUGH CAPITAL PARTNERS L P portfolio value:
$2.91M
portfolio value
CLOUGH CAPITAL PARTNERS L P quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -70.08% | -99.8K shares | -3.53M | $68.3 | 42.60K |
| Q2 2022 | share | 0.00% | 0 shares | -796K | $45.22 | 142.40K | |
| Q1 2022 | share | Increase | +8.09% | 10.66K shares | 1.00M | $50.81 | 142.40K |
| Q4 2021 | share | Decrease | -4.36% | -6K shares | 1.68M | $47.95 | 131.74K |
| Q3 2021 | share | 0.00% | 0 shares | -4.16M | $32.96 | 137.74K | |
| Q2 2021 | share | Decrease | -71.84% | -351.4K shares | -12.28M | $63.2 | 137.74K |
| Q1 2021 | share | Increase | +110.43% | 256.7K shares | 7.69M | $42.91 | 489.14K |
| Q4 2020 | share | Decrease | -42.72% | -173.38K shares | 1.05M | $57.2 | 232.44K |
| Q3 2020 | share | 0.00% | 0 shares | -1.01M | $30.17 | 405.83K | |
| Q2 2020 | share | 0.00% | 0 shares | 2.38M | $32.66 | 405.83K | |
| Q1 2020 | share | Decrease | -21.78% | -113K shares | -5.01M | $26.79 | 405.83K |
| Q4 2019 | share | 0.00% | 0 shares | 3.38M | $30.62 | 518.83K | |
| Q3 2019 | share | Decrease | -12.38% | -73.3K shares | -2.50M | $24.09 | 518.83K |
| Q2 2019 | share | Increase | +0.41% | 2.4K shares | 3.50M | $25.34 | 592.13K |
| Q1 2019 | share | Increase | +4.80% | 27K shares | 4.07M | $19.5 | 589.73K |
| Q4 2018 | share | Decrease | -4.48% | -26.38K shares | -3.05M | $13.19 | 562.73K |
| Q3 2018 | share | Increase | +1.99% | 11.5K shares | -2.23M | $17.78 | 589.11K |
| Q2 2018 | share | Decrease | -7.08% | -44K shares | -965K | $22 | 577.61K |
| Q1 2018 | share | Decrease | -32.22% | -295.5K shares | -5.99M | $22.11 | 621.61K |
| Q4 2017 | share | Increase | 0.00% | 917.11K shares | 19.66M | $21.7 | 917.11K |